Caris Life Sciences, Inc. (CAI) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Biotechnologie Branche. Der Hauptsitz des Unternehmens ist in Irving, TX, United States. Der aktuelle CEO ist David Dean Halbert.
CAI hat IPO-Datum 2025-06-18, 1,769 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $5.71B.
CAI International, Inc. is a transportation finance and logistics company headquartered in San Francisco, California, operating across North America, Europe, Asia, and other international markets. The company operates through two primary segments: Container Leasing, which involves leasing, re-leasing, and disposing of container equipment under various lease structures, as well as managing repair, repositioning, and storage services; and Logistics, which provides comprehensive domestic and international services including intermodal transportation, truck brokerage, port drayage, warehousing, ocean freight, air freight, and customs brokerage. As of December 31, 2019, CAI International maintained a container fleet of approximately 1.73 million cost equivalent units and offered technology-enabled transportation management solutions such as shipment optimization, load consolidation, and Web-based visibility platforms to support supply chain efficiency.
